SE400287B - Forfarande for framstellning av fluorsubstituerade tiaxantenderivat - Google Patents

Forfarande for framstellning av fluorsubstituerade tiaxantenderivat

Info

Publication number
SE400287B
SE400287B SE7316567A SE7316567A SE400287B SE 400287 B SE400287 B SE 400287B SE 7316567 A SE7316567 A SE 7316567A SE 7316567 A SE7316567 A SE 7316567A SE 400287 B SE400287 B SE 400287B
Authority
SE
Sweden
Prior art keywords
thiaxantene
fluoro
derivatives
substituted
procedure
Prior art date
Application number
SE7316567A
Other languages
English (en)
Swedish (sv)
Inventor
J L M Buus
N Lassen
A J Bigler
Original Assignee
Kefalas As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kefalas As filed Critical Kefalas As
Publication of SE400287B publication Critical patent/SE400287B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14[b,f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE7316567A 1972-12-08 1973-12-07 Forfarande for framstellning av fluorsubstituerade tiaxantenderivat SE400287B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5691072A GB1453828A (en) 1972-12-08 1972-12-08 Fluoro-substituted thiaxanthene derivatives

Publications (1)

Publication Number Publication Date
SE400287B true SE400287B (sv) 1978-03-20

Family

ID=10477876

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7316567A SE400287B (sv) 1972-12-08 1973-12-07 Forfarande for framstellning av fluorsubstituerade tiaxantenderivat

Country Status (19)

Country Link
JP (1) JPS594436B2 (fi)
AR (2) AR202805A1 (fi)
AT (1) AT332395B (fi)
BE (1) BE808347A (fi)
CH (2) CH592085A5 (fi)
CS (1) CS176259B2 (fi)
DE (1) DE2359359C3 (fi)
DK (1) DK145576C (fi)
ES (2) ES421098A1 (fi)
FI (1) FI57410C (fi)
FR (1) FR2209573B1 (fi)
GB (1) GB1453828A (fi)
HU (1) HU167778B (fi)
IE (1) IE38554B1 (fi)
NL (1) NL7316035A (fi)
NO (1) NO138806C (fi)
PL (1) PL95266B1 (fi)
SE (1) SE400287B (fi)
ZA (1) ZA738990B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
GB8628903D0 (en) * 1986-12-03 1987-01-07 Lunbeck A S H Neuroleptic compounds
US6395752B1 (en) * 1999-03-04 2002-05-28 Pharmaquest Limited Method of treating depression using 1-threo-methylphenidate
US6127385A (en) * 1999-03-04 2000-10-03 Pharmaquest Limited Method of treating depression using l-threo-methylphenidate
MX2009007235A (es) * 2007-01-05 2009-10-16 Bkg Pharma Aps "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585338A (fi) * 1958-12-04
FR1463787A (fr) * 1963-10-14 1966-07-22 Pfizer & Co C Composés de phosphonium aminoalcoyl-trisubstitués, dérivés de tels composés, et procédés pour leur préparation

Also Published As

Publication number Publication date
NO138806B (no) 1978-08-07
FI57410C (fi) 1980-08-11
DK145576B (da) 1982-12-13
JPS4994691A (fi) 1974-09-09
DE2359359C3 (de) 1978-11-02
DE2359359B2 (de) 1978-02-16
NO138806C (no) 1978-11-15
JPS594436B2 (ja) 1984-01-30
ES421098A1 (es) 1976-08-01
BE808347A (fr) 1974-03-29
FI57410B (fi) 1980-04-30
CH590272A5 (fi) 1977-07-29
GB1453828A (en) 1976-10-27
CS176259B2 (fi) 1977-06-30
FR2209573B1 (fi) 1977-12-09
ZA738990B (en) 1974-11-27
HU167778B (fi) 1975-12-25
IE38554L (en) 1974-06-08
AR202672A1 (es) 1975-06-30
CH592085A5 (fi) 1977-10-14
DE2359359A1 (de) 1974-06-27
AR202805A1 (es) 1975-07-24
PL95266B1 (pl) 1977-10-31
IE38554B1 (en) 1978-04-12
AT332395B (de) 1976-09-27
DK145576C (da) 1983-06-13
ES444294A1 (es) 1977-10-01
ATA1000373A (de) 1976-01-15
FR2209573A1 (fi) 1974-07-05
NL7316035A (fi) 1974-06-11
AU6296673A (en) 1975-05-29

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE404525B (sv) Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe